A crown ether-based porous organic polymer and its preparation method and application
By preparing crown ether-based porous organic polymers with multiple twisted structures, the problems of reduced photoactivity and poor penetration of existing porphyrin-based photosensitizers are solved, and the treatment of efficient bactericidal and deep infection under 808nm near-infrared light is achieved. Significantly improves antibacterial effect and biocompatibility.
Patent Information
- Application Number
- CN202411110511.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-08-14
AI Technical Summary
The rapid evolution of existing antibiotic resistance has led to open wound infection becoming a serious health threat. The existing porphyrin-based photosensitizers have problems of reduced photoactivity and poor penetration in the treatment, making it difficult to effectively kill deeply infected bacteria.
Using tetra-1,4-bis(4-aldehyde phenyl)phenylporphyrin and orthophenyldiamine-18-crown ether-6 as structural units, a crown ether-based porous organic polymer with multiple twisted structures can be prepared. Photodynamic and photothermal therapy are achieved under near-infrared light of 808nm, improving the absorption wavelength and biocompatibility of photosensitizers.
It improves the bactericidal effect and biocompatibility of photosensitizers, can effectively kill Gram-positive and negative bacteria, significantly promotes the healing of open bacterial infection wounds, and provides a new photosensitive sterilizer to fight drug-resistant infections.
Smart Images

Figure CN118652398B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine technology, and in particular to a crown ether-based porous organic polymer and a preparation method and application thereof. Background Art
[0002] Open wound infections have become one of the most serious health threats worldwide due to the widespread emergence of antibiotic resistance. To date, studies by the World Health Organization have shown that infections caused by antibiotic-resistant bacteria have become the leading cause of death each year in developing countries, placing a huge economic burden on society. The pace of development of new antibiotics lags far behind the emergence of antibiotic resistance, further deepening the clinical dilemma. At the same time, frequent reports indicate that antibiotics affect the balance of bacterial strains and significantly accelerate the evolution of resistance. Therefore, in order to effectively respond to the resistance crisis, new antimicrobial methods or strategies are urgently needed to avoid the emergence of resistance.
[0003] With the development of medicine, clinical and scientific researchers have been making every effort to develop new antibacterial drugs as alternatives to antibiotics. Phototherapy, as an emerging antibiotic-free sterilization method, has flourished in recent years. Unlike other treatment methods, phototherapy is a non-invasive sterilization method that uses photosensitizers (PS) to exert antibacterial effects under near-infrared laser irradiation light of a specific wavelength. Photodynamic therapy (PDT) uses a specific wavelength to enable photosensitizers to transfer energy to surrounding oxygen and convert it into toxic singlet oxygen to kill bacteria, and photothermal therapy (PTT) converts light energy into heat energy to kill bacteria. These two methods are the most common sterilization methods that do not induce resistance. Many reports have shown that the therapeutic effects of PDT and PTT are determined by photosensitizers. Inorganic photosensitizers are hindered by the inherent toxicity of metal-based particles; compared with inorganic photosensitizers, organic photosensitizers have higher application prospects. However, the presence of inherent conjugated structures in organic photosensitizers greatly reduces the therapeutic effect. For example, porphyrin has certain photosensitivity and can effectively release singlet oxygen under the action of ultraviolet or visible light. However, when porphyrin is used to prepare photosensitizers, porphyrin monomers aggregate through π-π interaction during the stacking process, and their photoactivity is quenched. Patent No. 2024108226118 discloses a covalent organic framework antibacterial material based on polyoxyvanadium, which is polymerized with octaaldehyde porphyrin and tetra(6-methylpyridin-3-yl)porphyrin as the result units. Although the photoactivity of the polymer is not quenched, the 638 nm laser is used for treatment, and the photosensitivity effect needs to be improved and the penetration is poor, and the therapeutic effect on deep infection needs to be improved. Therefore, it is necessary to develop an efficient photosensitizer containing porphyrin, the photoactivity is not quenched, and effective sterilization is achieved through bio-friendly, tissue-penetrating near-infrared light-induced photodynamic therapy and photothermal therapy; effective sterilization is achieved under the condition of biocompatibility and no drug resistance. Summary of the invention
[0004] In view of the above-mentioned prior art, the purpose of the present invention is to provide a crown ether-based porous organic polymer and its preparation method and application. The present invention uses tetrakis-1,4-di(4-formaldehydephenyl)phenyl)porphyrin (TTEP) and o-phenylenediamine-18-crown-6 (TAC) as structural units to prepare a high-efficiency photosensitizer with a multiple twisted structure, which can achieve photodynamic and photothermal therapy sterilization under 808nm near-infrared light, thereby increasing the absorption wavelength of existing porphyrin photosensitizers, thereby reducing the energy required for treatment and improving the biocompatibility and sterilization effect of the photosensitizer.
[0005] To achieve the above object, the present invention adopts the following technical solution:
[0006] The first aspect of the present invention provides a method for preparing a crown ether-based porous organic polymer, the preparation method comprising:
[0007] Tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin and di-o-phenylenediamine-18-crown-6 are dissolved in an organic solvent, a catalyst is added, and then reacted in a closed environment. After the reaction is completed, the product is filtered, washed and dried to obtain a black powder, which is a crown ether-based porous organic polymer.
[0008] Preferably, the di-o-phenylenediamine-18-crown ether-6 is prepared by the following method:
[0009] (1) Add 2,4-dibenzo-18-crown-6 to dichloromethane, slowly add concentrated nitric acid dropwise under stirring to react, then add concentrated sulfuric acid, stir at room temperature to precipitate crystals, filter, wash and dry to obtain yellow powder tetranitrobenzene-18-crown-6;
[0010] (2) Tetranitrobenzene-18-crown-6 and Pd / C catalyst are added to ethanol, and then hydrazine hydrate is added. The mixture is refluxed and stirred under a protective atmosphere. After the reaction is completed, the mixture is naturally cooled to room temperature. The crystals are collected and dried in vacuo to obtain white needle-shaped crystals, which are di-o-phenylenediamine-18-crown-6.
[0011] Preferably, the tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin is prepared by the following method:
[0012] (1) 3,5-dibromobenzaldehyde is dissolved in propionic acid, and then heated to reflux, pyrrole is added, and the heating reaction is continued. After filtering, washing, and drying, a solid is obtained;
[0013] (2) The solid obtained in step (1) is mixed with p-formylphenylboronic acid, tetrakis(triphenylphosphine)palladium and potassium carbonate, tetrahydrofuran and anoxic water are added under a protective atmosphere, heated to react, and then washed and purified to obtain tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin.
[0014] Preferably, the molar ratio of the tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin to di-o-phenylenediamine-18-crown-6 is 1:2.
[0015] Preferably, the organic solvent is at least one of mesitylene and 1,4-dioxane; and the catalyst is p-toluenesulfonic acid.
[0016] Preferably, the ratio of the added amounts of the tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin, the organic solvent and the catalyst is 181 mg:10 mL:300 mg; and the volume ratio of the mesitylene and 1,4-dioxane is 1:1.
[0017] Preferably, the reaction temperature is 120° C. and the reaction time is 5 days.
[0018] The second aspect of the present invention provides a crown ether-based porous organic polymer prepared by the above method, wherein the crown ether-based porous organic polymer has a multi-distorted structure: the overall structure of the crown ether-based porous organic polymer is distorted, and the crown ether contained in the crown ether-based porous organic polymer also has a distorted structure.
[0019] Preferably, the absorption wavelength of the crown ether-based porous organic polymer is 200 to 900 nm.
[0020] The third aspect of the present invention provides the use of crown ether-based porous organic polymers in the preparation of antibacterial drugs or photosensitizers.
[0021] Beneficial effects of the present invention:
[0022] (1) The present invention uses tetrakis-1,4-di(4-formaldehydephenyl)phenyl)porphyrin (TTEP) and o-phenylenediamine-18-crown-6 (TAC) as structural units to prepare a high-efficiency photosensitizer with a multi-twisted structure, which can achieve photodynamic and photothermal therapy sterilization under 808nm near-infrared laser, thereby increasing the absorption wavelength of existing porphyrin photosensitizers, thereby reducing the energy required for treatment and improving the biocompatibility and bactericidal effect of the photosensitizer.
[0023] (2) The crown ether-based porous organic polymer prepared by the present invention has a three-dimensional distorted structure, which can effectively overcome the photosensitizer quenching caused by porphyrin self-aggregation. In addition to the inherent bactericidal properties, the simultaneous introduction of crown ether and imidazole bonds can significantly improve the adhesion of the material to bacteria through hydrogen bonds, thereby shortening the singlet oxygen ( 1In vivo and in vitro experiments have shown that Crown-TTEP, as a broad-spectrum antibacterial agent, has high PTT / PDT activity and crown ether skeleton characteristics under near-infrared laser irradiation, and has excellent antibacterial ability against both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) pathogens, significantly promoting the healing of open bacterial-infected wounds, and providing a paradigm for POP-based photosensitive sterilants. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 : a) FT-IR spectra of Crown-TTEP, TTEP and TAC; b) FT-IR spectra of Crown-TTEP 13 C CP MAS solid NMR spectrum; c) Thermogravimetric analysis of Crown-TTEP; d) Powder XRD of Crown-TTEP; e) Low-temperature N2 adsorption-desorption curve of Crown-TTEP; f) UV-visible spectra of Crown-TTEP at different concentrations;
[0025] Figure 2 :a) SEM image of Crown-TTEP at 1 μm; b) SEM image of Crown-TTEP at 200 nm; c)~f) TEM and HR-TEM images of Crown-TTEP at 1 μm, 200 nm, 50 nm and 10 nm respectively; g)~j) are elemental mapping images of Crown-TTEP;
[0026] Figure 3 :a) Concentration-dependent photothermal effect of Crown-TTEP under near-infrared (808 nm, 1.2 W / cm²) irradiation for 10 min; b) Photothermal effect of Crown-TTEP under near-infrared light irradiation of different powers (808 nm, 1.2 W / cm²); c) Infrared thermal images of Crown-TTEP under different concentrations and irradiation times; d) Temperature change curve of Crown-TTEP (200 μg / mL) under 4 on / off cycles of laser irradiation (808 nm, 1.2 W / cm²); e) Temperature change curve of Crown-TTEP (200 μg / mL) after near-infrared light irradiation (808 nm, 1.2 W / cm²); f) Negative natural logarithm of cooling time to temperature; g) UV-visible spectrum of Crown-TTEP (200 μg / mL) under near-infrared light irradiation (808 nm, 1.2 W / cm²); h) Near-infrared (808 nm, 1.2 Comparison of the decay rate of Crown-TTEP-induced DPBF under irradiation of 100 W / cm2;
[0027] Figure 4:a) Photos of Staphylococcus aureus and Escherichia coli colonies treated with different concentrations of Crown-TTEP; b) Bacterial activity of Escherichia coli under different concentrations of Crown-TTEP; c) Bacterial activity of Staphylococcus aureus under different concentrations of Crown-TTEP; d) Photos of Escherichia coli and Staphylococcus aureus colonies on agar plates after four different treatments; e) Bacterial activity of Escherichia coli after four different treatments; f) Bacterial activity of Staphylococcus aureus after four different treatments; The results are expressed as mean ± standard deviation (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, analysis of variance);
[0028] Figure 5 :a) Fluorescence images of Staphylococcus aureus and Escherichia coli co-stained with SYTO 9 in the four groups of treatments (scale bar = 200 μm); b) TEM images of Staphylococcus aureus and Escherichia coli incubated with the four groups of treatments, the red tip in the figure is the damage site (scale bar = 2 μm);
[0029] Figure 6 :a) Crown-TTEP cell scratch test; b) Cell migration rate of Crown-TTEP and control group at different times; c) Crown-TTEP hemolysis test; d) Representative photos of wound tissues corresponding to the wounds of groups II to V on days 0-8, with the traces of wound closure on the right during the treatment process; e) Weight changes of the five groups during the treatment period; f) Wound healing rate of groups II to V during the treatment process;
[0030] Figure 7 : a) H&E and Masson-stained sections of wound skin tissue 8 days after treatment (scale bar = 500 μm); b) H&E-stained sections of tissues (heart, liver, spleen, lung and kidney) of the five groups;
[0031] Figure 8 :a) Red blood cell test, b) Mean corpuscular volume test; c) Mean hemoglobin concentration test; d) Evaluation of hemoglobin amount test; e) Hemoglobin test; f) Hematocrit test;
[0032] Fig. 9 :Schematic diagram of the synthesis and bactericidal properties of Crown-TTEP. DETAILED DESCRIPTION
[0033] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.
[0034] As introduced in the background technology section, although the existing porphyrin-based POP has a three-dimensional spatial structure, it forms a porous structure through π-π accumulation during the polymerization process, which cannot effectively overcome the problem of reduced photosensitivity caused by porphyrin self-aggregation.
[0035] Based on this, the object of the present invention is to provide a crown ether-based porous organic polymer and a preparation method and application thereof. Fig. 9 As shown, the present invention uses tetrakis-1,4-di(4-formaldehydephenyl)phenyl)porphyrin (TTEP) and o-phenylenediamine-18-crown-6 (TAC) as structural units to prepare a porous organic polymer having three ring structures of imidazole ring, porphyrin ring and crown ether ring. Crown-TTEP itself has a twisted structure, and the crown ether contained in the polymer also has a twisted structure, thereby forming a multiple twisted structure. The twisted structure design effectively overcomes the problem of reduced photosensitivity caused by porphyrin self-aggregation and enhances the photosensitivity. In addition, TTEP and TAC are combined by the reaction of the aldehyde group of TTEP with the two amine groups of TAC. At the same time, the aldehyde group of TTEP and the two amine groups of TAC generate an imidazole ring with a bactericidal effect, further improving the bactericidal effect of Crown-TTEP. Crown-TTEP breaks the infrared absorption wavelength of the existing porphyrin-based POP, increases the wavelength by more than 200nm, and can absorb near-infrared light in the range of 200 to 900nm. Taking 808nm as an example, it belongs to near-infrared light, which reduces the energy required for Crown-TTEP during photothermal sterilization, greatly reduces damage to normal tissues, can kill bacteria deeper in the wound, and has better biocompatibility.
[0036] In order to enable those skilled in the art to more clearly understand the technical solution of the present application, the technical solution of the present application will be described in detail below in conjunction with specific embodiments.
[0037] Note: Unless otherwise specified, the lasers used in the present invention are all near-infrared light irradiation (wavelength 808nm);
[0038] Unless otherwise specified, the pH of PBS used in the present invention is neutral.
[0039] The test materials used in the examples of the present invention are all conventional test materials in the art and can be purchased through commercial channels.
[0040] Example 1: Preparation of Crown-TTEP
[0041] (1) Preparation of tetrakis-1,4-di(4-formaldehydephenyl)phenyl)porphyrin (TTEP)
[0042] 3,5-Dibromobenzaldehyde (2.11 g, 8 mmol) was added to a 250 mL dry round-bottom flask. 120 mL of propionic acid was poured into the round-bottom flask to dissolve the sample. Pyrrole (0.5 mL, 7.45 mmol) was added dropwise to the reaction system (the whole process took about 30 minutes), and then the system was maintained at 140 ° C for 4 hours, then cooled to room temperature and filtered, and the product was washed with 70 ° C hot water and ethanol in turn. The product was then transferred to a vacuum oven, vacuumed at 80 ° C, and dried for 12 hours to obtain solid 5,10,15,20-tetrakis (3,5-dibromophenyl) porphyrin (1.74 g, yield 70%), which can be used in the next step without further purification.
[0043] 5,10,15,20-Tetrakis(3,5-dibromophenyl)porphyrin (371 mg, 0.3 mmol), p-formylphenylboronic acid (600 mg, 4.0 mmol), Pd(PPh3)4 (85 mg, 0.70 mmol) and anhydrous K2CO3 (0.95 g, 6.8 mmol) were added to a 100 mL dry Schlenk tube and reacted in vacuum for 30 min. Under argon protection, tetrahydrofuran and distilled water were evacuated in advance to obtain oxygen-free THF and oxygen-free distilled water, and 30 mL of oxygen-free tetrahydrofuran THF and 10 mL of oxygen-free distilled water were added. The system was heated to 100 ° C and stirred for 3 days. After cooling, the water layer was extracted with DCM, and the crude solid was distilled under reduced pressure and washed with methanol. Purification by silica gel column chromatography, the eluent was methanol: dichloromethane = 1:15 (volume ratio) to obtain a purple solid, which is TTEP, with a yield of 75%.
[0044] (2) Preparation of o-phenylenediamine-18-crown-6 (TAC)
[0045] Add 2,4-dibenzo-18-crown-6 (2.16 g, 6.0 mmol) and 200 mL of dichloromethane to a 500 mL three-necked flask. Under stirring, slowly add 15 mL of concentrated nitric acid (68%) at a rate of 5 seconds per drop. After reacting for 10 min, add 7.5 mL of 80% concentrated sulfuric acid and stir at room temperature for 3 days, during which a large amount of crystals precipitate. Wash the crystals with water and ethanol in turn. After filtering, dry the crystals in a vacuum at 80 ° C for 10 h to obtain 2.36 g of yellow powder tetranitrobenzene-18-crown-6 with a yield of 85%. The synthetic route is as follows:
[0046] .
[0047] Tetranitrobenzene-18-crown-6 (1.0 g, 2.2 mmol) and Pd / C catalyst (0.5 g, 4.7 mmol, Pd content is 20wt%) were added to a three-necked round-bottom flask. Under argon protection, 40 mL of ethanol was added to the reaction system, argon was purged for 30 min (air was exhausted), and 150 mL of hydrazine hydrate was injected into the flask at 5 seconds / drop using a syringe. The reaction system was refluxed and stirred at 80°C for 4 h under argon atmosphere, and the reaction system was naturally cooled to room temperature. After crystallization, it was filtered and vacuum dried at 80°C for 10 h. The final product was white needle-shaped crystals, namely TAC. The synthesis route is as follows:
[0048] .
[0049] (3) Preparation of Crown-TTEP
[0050] TTEP (181 mg, 0.125 mmol), TAC (105 mg, 0.25 mmol), 5.0 mL of mesitylene and 5.0 mL of 1,4-dioxane were added to a Schlenk tube. The solution was ultrasonicated for 5 min, and then 0.3 g of p-toluenesulfonic acid was added to the Schlenk tube as a catalyst. The glass ampoule was quickly frozen at 77 K using a liquid nitrogen bath, thawed three times with a freeze pump for degassing, and then sealed with plastic wrap. The Schlenk tube was reacted at 120 ° C for 5 days. After the reaction was completed, the reaction mixture was washed with DMF, DCM, THF and methanol in sequence to obtain a black powder, which was Crown-TTE (0.38 g, yield 64%). The synthetic route is as follows:
[0051] .
[0052] Example 2: Characterization of Crown-TTEP
[0053] (1) The structure of CROWN-TTEP prepared in Example 1 was characterized.
[0054] like Figure 1 As shown in a), CROWN-TTEP combines the characteristics of both TAC and TTEP structural units, with the peaks at 2816 and 1350 cm -1 The typical vibration bands of crown ether CH and COC can be clearly observed at 1343 cm -1 The amine (3421 cm -1 ) and aldehydes (1633 cm -1) almost disappears after the formation of Crown-TTEP. In contrast, the typical stretching vibrations at 2360 and 1616 cm -1 The characteristic vibrations of the newly formed imidazole bonds are similar to the FTIR results.
[0055] Figure 1 b) Medium solid 13 The C CP / MAS NMR spectrum showed that Crown-TTEP integrated the carbon signals of porphyrin (138.8 and 145.8 ppm) and crown ether (69.8 ppm). In addition, the remaining two carbon signals 106.6 and 171.1 ppm belonged to the carbon in the newly formed imidazole unit. The above spectra confirmed the successful formation of the Crown-TTEP porous framework.
[0056] The thermal stability of Crown-TTEP was evaluated by thermogravimetric (TG) curve. Figure 1 As shown in Figure 3, Crown-TTEP is stable at 400 °C. The slight weight loss below 100 °C is due to the strong evaporation of water absorbed by the highly polar skeleton. When the temperature is increased to 800 °C, the remaining weight of Crown-TTEP still remains above 45% of the initial weight, indicating that Crown-TTEP has good thermal stability.
[0057] The crystal structure of Crown-TTEP was characterized by powder X-ray diffraction (XRD). Figure 1 As shown in d), Crown-TTEP only shows a featureless broad peak at around 23°C, indicating its amorphous structure.
[0058] The pore distribution of Crown-TTEP can be understood through the N2 adsorption-desorption curve and pore size distribution curve. Figure 1 As shown in Figure 5e), Crown-TTEP exhibits a typical type II isotherm with a large hysteresis loop at the branch of the adsorption and desorption curves, as well as rapid absorption in the high pressure range (P / P0>0.8), which indicates that the material is mainly mesoporous.
[0059] Figure 1 f) Ultraviolet-visible (UV-vis) spectroscopy reveals the optical and physical properties of Crown-TTEP. Crown-TTEP has a broad spectrum of light absorption in the wavelength range of 200 to 900 nm, which is positively correlated with the Crown-TTEP concentration, indicating that it has good application potential as a phototherapeutic agent.
[0060] The morphology and microstructure of Crown-TTEP were studied using scanning electron microscopy and transmission electron microscopy. Figure 2 a) ~ Figure 2 f) It can be seen that Crown-TTEP is a bulk material formed by the stacking of flake structures, and Crown-TTEP has a rough surface and hierarchical pores (macroporous and mesopores). Figure 2 f) High-resolution transmission electron microscopy (HR-TEM) shows that the macropores are uniformly distributed in the polymer backbone, as can be seen from the light and dark contrast. Figure 2 g) ~ Figure 2 j) Elemental mapping shows the uniform distribution of C, O, and N elements in Crown-TTEP.
[0061] (2) Testing the photothermal conversion performance of CROWN-TTEP prepared in Example 1
[0062] Crown-TTEP aqueous solutions of different concentrations (0, 50, 100, 200, 300 μg / mL) were added to 1.5 mL centrifuge tubes. The total volume of Crown-TTEP aqueous solution in each centrifuge tube was 1 mL. Each centrifuge tube was placed in a 1.2 W cm -2 The samples were irradiated with infrared laser for 10 min. The temperature values were displayed on a thermal imaging display, and the temperature rise within 10 min was plotted every 40 s. In addition, a 200 μg / mL Crown-TTEP aqueous suspension was prepared and the samples were irradiated with power densities of 1, 1.2, and 1.5 W cm -2 The 808 nm laser was irradiated for 10 min, and data was collected every 40 s for plotting. Subsequently, the thermal stability of Crown-TTEP was evaluated by heating / cooling cycle experiments with on / off near-infrared laser. The prepared Crown-TTEP aqueous suspension (200 μg / mL) was irradiated with infrared laser (power density 1.2 W cm -2 ), after irradiation for 10 min, turn off the laser and let Crown-TTEP cool naturally to room temperature. Then repeat the cycle 4 times in the same way and record the temperature change during the whole cycle. Take out one of the cycles separately and draw a graph, and calculate the photothermal conversion efficiency by the temperature change during the descending process.
[0063] like Figure 3 As shown in Figures 3a) and 3b), the photoheating performance of Crown-TTEP depends on the concentration and laser power density. Under near-infrared light (808 nm, 1.2 W / cm²), when the Crown-TTEP concentration is 100 μg / mL and 200 μg / mL, the temperature of the Crown-TTEP aqueous solution rises rapidly to about 52.1 ℃ and 60.1 ℃ within 10 min, which is much higher than pure water (31.5 ℃). Figure 3c) The infrared thermography images recorded by the infrared camera can also verify the light-induced temperature rise behavior. In addition, in order to effectively evaluate the photothermal stability of Crown-TTEP, laser on / off cycle experiments were performed. These results show that by changing the concentration of Crown-TTEP or the laser power, near-infrared radiation (808nm) can be converted into thermal energy to achieve the desired therapeutic effect. Figure 3 As shown in d), under the condition that the maximum temperature is almost constant, Crown-TTEP still has a high efficiency of photothermal effect after four repeated on / off cycles, indicating that Crown-TTEP has excellent stability. Figure 3 e) and Figure 3 f) According to the photothermal conversion efficiency formula in the application number CN202310175497.X published in "A photothermal-Fenton-like reaction artificial nanozyme and its preparation method and application", the photothermal conversion efficiency (η) of Crown-TTEP is calculated to be 44.6% (in the photothermal conversion efficiency formula, the laser parameters are 808 nm and 1.2 W / cm², so A 808 = 0.3087, the value of τS is calculated to be 266.55, and the value of hS is further calculated to be 1.58×10 -2 ). The photothermal conversion efficiency is comparable to that of most POP-based photosensitizers. These results strongly confirm that the prepared Crown-TTEP has great potential as an effective photosensitizer for specific biomedical applications.
[0064] (3) Singlet oxygen and oxygen production capacity test.
[0065] First, prepare the DPBF probe solution (dissolve 50 μL of DPBF in 3 mL of DMSO solution) and adjust its absorbance to about 1.0. Irradiate with 808 nm laser for 0, 2, 4, 6, 8, and 10 min, and measure its UV absorption, respectively, to prove the stability of the DPBF probe. Subsequently, prepare the DMSO solution of Crown-TTEP and add 50 μL of DPBF probe so that the probe has an initial absorbance of about 1.0, and the irradiation time is consistent with the previous one. Detect the UV absorption after near-infrared laser irradiation, and plot the CROWN-TTEP UV absorption.
[0066] Using 1,3-diphenylisobenzofuran (DPBF) as a probe, the 1 The generation of O2 was used to study the PDT ability of Crown-TTEP. Figure 3 g) and Figure 3h) shows that under laser irradiation, the absorbance decay of DPBF in the presence of Crown-TTEP at ~415 nm is much higher than that of pure DPBF. The solution treated with Crown-TTEP exhibits a rapid decay of 72.7% within 10 min of near-infrared laser irradiation, which is much higher than that of pure DPBF (3.94%), indicating that Crown-TTEP has excellent ROS generation ability and can provide effective PDT efficiency.
[0067] Test Example 1: In vitro antibacterial performance test
[0068] Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) were used as representatives of Gram-positive and Gram-negative bacteria to test the antibacterial properties of Crown-TTEP.
[0069] The specific culture method of the second generation bacteria is as follows: first, thaw the frozen bacteria at 37°C, take 100 µL of the bacterial solution in a shaking tube containing 5 mL of liquid culture medium, place it in a constant temperature shaker (110 rpm, 37°C) and culture it for 12 hours, take 100 µL of the cultured bacterial solution and place it in a 2 mL EP tube containing 900 µL of liquid culture medium, and then dilute it in a gradient of 10 -2 Dilute 5-10 tubes, take 100 µL of the bacterial solution in each tube, use a coating rod to evenly spread it on a culture dish containing solid culture medium, incubate at 37°C for 24 hours, observe the clone morphology and colony count, and take a culture dish with about 1000 colonies as the first generation of bacteria. Use a bacteria picker to pick out a colony from the first generation of bacteria and add it to a shaking tube containing 5 mL of liquid culture medium. Cultivate it according to the method of culturing first generation bacteria to obtain a culture dish with about 1000 colonies as the second generation of bacteria. The specific configuration method of liquid culture medium is: take 5g of LB broth, disperse it in 200 mL of distilled water, and then sterilize it by high pressure sterilization to obtain bacterial liquid culture medium. The specific configuration method of solid culture medium is: take 5g of LB broth and 3g of agar, disperse them in 200 mL of distilled water, and then sterilize them by high pressure sterilization to obtain solid culture medium.
[0070] (1) Determination of antibacterial activity of Crown-TTEP by plate count method
[0071] The preparation method of the dispersion of bacteria in the Crown-TTEP group with different concentrations was as follows: 2 mg of Crown-TTEP powder was fully dispersed in 2 mL PBS to prepare a 1 mg / mL Crown-TTEP stock solution, and 10 µL of 10 was added to each of the four 2 mL EP tubes. 8 CFU mL -1Bacterial solution (S. aureus or E. coli), then add 990, 890, 840, 790 μL of PBS, then add 0, 100, 150, 200 μL of 1 mg / mL CROWN-TTEP stock solution, to obtain 0, 100, 150, 200 μg / mL CROWN-TTEP and 10 8 CFU mL -1 The Crown-TTEP solution was obtained by irradiating the solution with laser (parameters of laser: λ = 808 nm, 1.2 W / cm 2 The above solutions were placed in a constant temperature shaker (110 rpm, 37 ° C) for 12 h, and then the cultured bacterial solution was gradiently diluted 10 5 Transfer 100 μL of the blown bacterial solution to the solid culture medium and spread it evenly with a spreading stick. Incubate at 37°C for 24 h, count the colonies and compare the bacterial activity of each group.
[0072] from Figure 4 a) It can be seen that under laser irradiation, the bactericidal ability of Crown-TTEP is positively correlated with its concentration. Figure 4 b) and Figure 4 As shown in Figure c), when the concentration of Crown-TTEP solution was 200 μg / mL, the inhibition rates against Staphylococcus aureus (96.86±0.21%) and Escherichia coli (91.07±0.44%) were both over 90%.
[0073] (2) In vitro antibacterial ability of Crown-TTEP under different treatments
[0074] The experiment was divided into 4 groups: I: PBS; II: PBS + near-infrared laser irradiation; III: Crown-TTEP; IV: Crown-TTEP + near-infrared laser irradiation. In the above groups, the total volume of each mixed solution was 1 mL, the bacterial solution concentration was 100 μL / mL (the number of colonies was 10 8 CFU mL -1 ), Crown-TTEP concentration was 200 μg / mL, and PBS was neutral. The laser group was irradiated with 808 nm near-infrared light with a power density of 1.2 W cm -2 Finally, the mixed solution of each group was placed in a shaker and incubated at 37°C for 24 h. 100 μL of the mixed solution of each group was transferred to the solid culture medium, the morphology was observed, and the number of colonies was calculated to evaluate the antibacterial effect.
[0075] like Figure 4As shown in Figure d), PBS only exhibited weak antibacterial activity. After treatment with Crown-TTEP, the activity of Escherichia coli and Staphylococcus aureus was significantly reduced to 50.17±4.15% and 46.05±3.25%, respectively, which was attributed to the inherent bacterial inactivation ability of Crown-TTEP. It is worth noting that Figure 4 e) and Figure 4 f) shows that after the near-infrared laser acted on Crown-TTEP, the survival rates of Escherichia coli and Staphylococcus aureus dropped sharply to 9.4±0.6% and 2.79±0.44%, respectively. These results indicate that Crown-TTEP not only has inherent antibacterial ability but also has excellent laser-induced PDT / PTT synergistic antibacterial effect.
[0076] Test Example 2: Bacterial staining test
[0077] (1) Bacterial live / dead staining
[0078] According to the method of Experimental Example 1, the mixture was divided into 4 groups (the total volume of the mixed solution in each group was 1 mL). 400 μL of solution was taken from each group, and 20 μL of SYTO-9 (1.0×10 -3 M) and 20 μL PI (1.5 × 10 -3 M), incubated at 37°C in the dark for 15 min. After staining, the mixture was centrifuged with PBS to remove excess SYTO-9 and PI. The bacteria in each solution were then resuspended with 50 μL PBS, 10 μL was aspirated and placed on the surface of the slide, and the stained Escherichia coli or Staphylococcus aureus images were observed under an inverted fluorescence microscope.
[0079] like Figure 5 As shown in a), regardless of laser irradiation or not, the bacteria treated with PBS only emitted strong green fluorescence labeled with SYTO 9, indicating that most of the bacteria survived. The results showed that after treatment with 200 μg / mL Crown-TTEP, both bacteria showed obvious red fluorescence labeled with PI, indicating that the inherent bactericidal effect of the POP skeleton led to bacterial death. Near-infrared irradiation (808 nm, 1.2 W cm -2 , 10 min), the proportion of dead bacteria increased significantly and the fluorescence signal was completely red.
[0080] (2) Morphology of bacteria under transmission electron microscopy
[0081] Divide into 4 groups according to the method of Experimental Example 1. Add 2.5wt% glutaraldehyde solution to each group of solutions, fix at 4℃ for 24h, then wash with PBS 3 times, embed and seal with agar. Treat the bacteria with 30 wt%, 50 wt%, 70 wt%, 90 wt%, 95 wt% and 100 wt% ethanol solutions in sequence for 10min to dehydrate them, then treat with acetone for 3h, and embed by gradient penetration. Finally, the bacteria were negatively stained, fixed on a nickel grid and observed by transmission electron microscopy.
[0082] like Figure 5 As shown in b), there is no significant difference between the surfaces of Staphylococcus aureus and Escherichia coli treated with PBS and PBS + laser. Their surfaces maintain a good smooth and complete morphology, with clear cell walls and dense intracellular substrates. The bactericidal effects of Groups I and II are negligible. In contrast, the bacterial cell walls treated only with Crown-TTEP are significantly deformed, which is due to the destruction of the bacterial cell membrane by the crown ether and imidazole effects. The effect of Crown-TTEP by near-infrared has a strong destructive effect on both bacteria, with obvious rupture of their cell membranes and leakage of cytoplasmic matrix, which is related to the synergistic effect of PDT / PTT under near-infrared irradiation.
[0083] Test Example 3: In vitro biocompatibility test
[0084] (1) Cell scratch test
[0085] Two 6-well plates were prepared, with 3 wells per group, divided into a control group (PBS) and a Crown-TTEP group (200 μg / mL). Mouse L929 fibroblasts (from the Cell Bank of the Chinese Academy of Sciences) were inoculated into 6-well plates and cultured for 24 h. The cells were then scraped with the tip of a sterile pipette and cultured for 12 h, followed by laser irradiation for 10 min. The cells were then rinsed with PBS, and phase contrast images were taken using a microscope at 0 h, 24 h, and 48 h. Image J software was used to measure the distance of cell migration and calculate the percentage of wound healing.
[0086] like Figure 6 As shown in a), the wound area is positively correlated with the incubation time. As the incubation time increases, the wound area gradually decreases. Figure 6 b) After 24 h, the cell migration rate in the Crown-TTEP group (49.72±1.81%) was better than that in the PBS group (26.44±1.7%), indicating that the synthesized Crown-TTEP can promote wound healing.
[0087] (2) Cell hemolysis experiment
[0088] The blood used in the experiment was taken from 5-week-old female KM mice (purchased from Jinan Pengyue Experimental Animal Breeding Co., Ltd.). The fresh blood was centrifuged (10000rpm, 20 min) and the supernatant was removed to collect red blood cells. Subsequently, PBS buffer was added for washing. The volume ratio of the added PBS buffer to the red blood cells was about 1:1. The supernatant was removed after centrifugation. This was repeated 4 times until the supernatant was clear. The red blood cells were then mixed with PBS buffer at a volume ratio of 3:11. The mixed red blood cells were mixed with Crown-TTEP (concentrations of 100, 200, 300, 400, 500 and 600 μg / mL) at a ratio of 1:9 (v / v) and incubated at 37°C for 4h. 100 μL of the supernatant from each tube was added to a 96-well plate, and the absorbance was measured with an enzyme reader. Distilled water was the positive control, and the PBS group was the negative control. The calculation formula is as follows:
[0089] Hemolysis rate (%) = (A-An) / (Ap-An) × 100%;
[0090] A: absorbance of the supernatant obtained after adding Crown-TTEP to red blood cells and centrifuging;
[0091] An: absorbance obtained by taking the supernatant after adding PBS to red blood cells (negative control);
[0092] Ap: absorbance of the supernatant after adding distilled water to red blood cells (positive control).
[0093] like Figure 6 c), the hemolysis rate of Crown-TTEP did not change much in the concentration range of 100 ~ 600 μg / mL and remained within the safe range (<4%), indicating that the synthesized Crown-TTEP has good blood biocompatibility.
[0094] Test Example 4: Wound healing experiment
[0095] The mice were all 8-week-old female Kunming mice (purchased from Jinan Pengyue Experimental Animal Breeding Co., Ltd.) to establish the wound trauma model. The mice were randomly divided into 5 groups: I: blank group, II: PBS group, III: PBS + near-infrared laser irradiation group, IV: Crown-TTEP group (200μg / mL), V: Crown-TTEP (200μg / mL) + near-infrared laser irradiation group; 3 mice in each group. Before the formal infection, the weight of each group of mice was weighed. Except for the blank group, the mice in other groups were anesthetized, the hair on the back was shaved, and the wound was disinfected with 75wt% ethanol to form a wound with a radius of about 5mm. Staphylococcus aureus (1×10 6CFU / mL), 24 hours after infection, the mice were divided into groups and treated according to the groups. In the above groups, the laser wavelength was 808nm and the laser irradiation power was 1.2 W cm -2 The irradiation time was 10 min. On the second day, a large number of Staphylococcus aureus appeared in the bacterial culture of the wound secretions in each group of mice, confirming that the wound infection model was successfully established.
[0096] The changes of the back wounds of mice on days 0, 2, 4, 6, and 8 were recorded, and the weight of mice was monitored every day. The weight changes and back wound areas of mice were plotted. On day 8, mice were anesthetized, and the eyeballs were removed to collect blood. After blood collection, the mice were killed, and the back wounds and major organ tissues (heart, liver, spleen, lung, and kidney) were fixed with 10% formalin, and then H&E staining and Masson trichrome staining were performed. 2 mL of blood was taken from each group for routine blood tests.
[0097] Figure 6 d) shows the recovery of the wound during the 8-day treatment period. It can be clearly seen that the wound area of each group of mice gradually decreased to varying degrees as the treatment time prolonged. Among them, the mice treated with Crown-TTEP+ laser had the fastest healing speed. Figure 6 f), compared with the blank group, the wounds of the mice treated with Crown-TTEP and Crown-TTEP+laser groups had scabs on the 4th day, and the wound healing rates were 47.81±1.66% and 54.8±1.44%, respectively, which were much higher than those of the PBS group (29.76±2.30%) and the PBS+near-infrared laser irradiation group (30.31±3.02%). On the 8th day, the wound healing rate of the Crown-TTEP+near-infrared laser irradiation group was 94.94±1.47%, which was also significantly higher than that of the other three groups: 85.67±2.16% in the Crown-TTEP group, 55.79±2.51% in the PBS group, and 62.56±2.45% in the PBS+near-infrared laser irradiation group. These results show that Crown-TTEP itself also has the ability to promote wound healing, which is due to the strong bactericidal properties of the polymer skeleton, which can accelerate the rapid healing of wounds. These results further demonstrate the great advantage of Crown-TTEP+NIR in playing a synergistic therapeutic role against bacterially infected wounds.
[0098] In summary, Crown-TTEP has inherent bactericidal ability. It can not only catalyze ground state oxygen to generate singlet oxygen, but also convert near infrared into local hyperthermia, quickly triggering the death of Staphylococcus aureus in the infected area, and has excellent synergistic and amplified therapeutic effects. Figure 6e) The weight change curve shows that the weight changes in the Crown-TTEP group and the Crown-TTEP + near-infrared laser irradiation group are basically consistent with those in the PBS group and the PBS + near-infrared laser irradiation group, and the weight changes gradually increase over time, indicating that these two treatments are well tolerated. Figure 7 As shown in a), after 8 days of treatment, different degrees of newly formed granulation tissue, including proliferative fibroblasts and regenerated thin-walled capillaries, were clearly detected in each group. Compared with the PBS and PBS+near-infrared laser irradiation groups, the wound area in the Crown-TTEP group and Crown-TTEP+near-infrared laser irradiation group was significantly reduced, especially in the Crown-TTEP+near-infrared laser irradiation group, the scab was almost restored and the complete dermal tissue was reconstructed. In the PBS and PBS+laser groups, mice had severe inflammatory cell infiltration, persistent scabs, and significantly incomplete epidermal tissue. These results further prove that Crown-TTEP can accelerate the healing of infected wounds, especially under near-infrared laser irradiation, the wound healing speed is faster.
[0099] Figure 7 b) H&E staining was used to evaluate the biosafety of Crown-TTEP on the main organs of mice. It can be seen that the morphology of the main organs (heart, liver, spleen, lung, and kidney) of the mice in the Crown-TTEP group and the Crown-TTEP + near-infrared laser irradiation group was similar to that of the PBS group and the PBS + near-infrared laser irradiation group. There was no histopathological abnormality after 8 days of treatment. Blood routine analysis was performed to evaluate biochemical indicators. The corresponding results are shown in Figure 8 As shown, the blood components of mice were within the safe range.
[0100] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A crown ether-based porous organic polymer, characterized in that: The crown ether-based porous organic polymer has a multi-distorted structure: the overall structure of the crown ether-based porous organic polymer is distorted, and the crown ether contained in the crown ether-based porous organic polymer also has a distorted structure; the absorption wavelength of the crown ether-based porous organic polymer is 200 to 900 nm; The crown ether-based porous organic polymer is prepared by the following method: Tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin and di-o-phenylenediamine-18-crown-6 are dissolved in an organic solvent, a catalyst is added, and then the reaction is carried out in a closed environment. After the reaction is completed, the product is filtered, washed, and dried to obtain a black powder, which is a crown ether-based porous organic polymer; The molar ratio of tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin to di-o-phenylenediamine-18-crown-6 is 1:2; the organic solvent is at least one of mesitylene and 1,4-dioxane; and the catalyst is p-toluenesulfonic acid.
2. The crown ether-based porous organic polymer according to claim 1, characterized in that: The di-o-phenylenediamine-18-crown ether-6 is prepared by the following method: (1) Add 2,4-dibenzo-18-crown-6 to dichloromethane, slowly add concentrated nitric acid dropwise under stirring to react, then add concentrated sulfuric acid, stir at room temperature to precipitate crystals, filter, wash and dry to obtain yellow powder tetranitrobenzene-18-crown-6; (2) Tetranitrobenzene-18-crown-6 and Pd / C catalyst are added to ethanol, and then hydrazine hydrate is added. The mixture is refluxed and stirred under a protective atmosphere. After the reaction is completed, the mixture is naturally cooled to room temperature. The crystals are collected and dried in vacuo to obtain white needle-shaped crystals, which are di-o-phenylenediamine-18-crown-6.
3. The crown ether-based porous organic polymer according to claim 1, characterized in that: The tetrakis-1,4-di(4-aldehydephenyl)phenylporphyrin is prepared by the following method: (1) 3,5-dibromobenzaldehyde is dissolved in propionic acid, and then heated to reflux, pyrrole is added, and the heating reaction is continued. After filtering, washing, and drying, a solid is obtained; (2) The solid obtained in step (1) is mixed with p-formylphenylboronic acid, tetrakis(triphenylphosphine)palladium and potassium carbonate, tetrahydrofuran and anoxic water are added under a protective atmosphere, heated to react, and then washed and purified to obtain tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin.
4. The crown ether-based porous organic polymer according to claim 1, characterized in that: The ratio of the added amounts of tetrakis-1,4-di(4-formaldehydephenyl)phenylporphyrin, the organic solvent and the catalyst is 181 mg:10 mL:300 mg; the volume ratio of mesitylene and 1,4-dioxane is 1:
1.
5. The crown ether-based porous organic polymer according to claim 1, characterized in that: The reaction temperature is 120° C. and the reaction time is 5 days.
6. Use of the crown ether-based porous organic polymer according to any one of claims 1 to 5 in the preparation of antibacterial drugs or photosensitizers.
